Report cover image

Global Nateglinide Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 88 Pages
SKU # APRC20354898

Description

Summary

According to APO Research, The global Nateglinide market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Nateglinide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Nateglinide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Nateglinide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Nateglinide include Qilu Pharmaceutical Co., Ltd, Chen Ho Pharmaceutical Co.,Ltd.Sinying Plant, Jiangsu Deyuan Pharmaceutical Co. Ltd, Beijing Novartis Pharmaceutical Co. Ltd, Nivagen Pharmaceuticals, Inc., NIKSAN PHARMACEUTICAL, Caremark L.L.C. and AvKARE, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nateglinide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nateglinide.

The Nateglinide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nateglinide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Nateglinide Segment by Company

Qilu Pharmaceutical Co., Ltd
Chen Ho Pharmaceutical Co.,Ltd.Sinying Plant
Jiangsu Deyuan Pharmaceutical Co. Ltd
Beijing Novartis Pharmaceutical Co. Ltd
Nivagen Pharmaceuticals, Inc.
NIKSAN PHARMACEUTICAL
Caremark L.L.C.
AvKARE, Inc.

Nateglinide Segment by Type

Tablet
Capsule

Nateglinide Segment by Application

Used In Combination With Metformin
Used Alone

Nateglinide Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nateglinide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nateglinide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nateglinide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nateglinide companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Table of Contents

88 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Nateglinide Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Nateglinide Market Size by Region (2020-2031)
1.4.1 Global Nateglinide Market Size by Region (2020-2025)
1.4.2 Global Nateglinide Market Size by Region (2026-2031)
1.5 Key Regions Nateglinide Market Size (2020-2031)
1.5.1 North America Nateglinide Market Size Growth Rate (2020-2031)
1.5.2 Europe Nateglinide Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Nateglinide Market Size Growth Rate (2020-2031)
1.5.4 South America Nateglinide Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Nateglinide Market Size Growth Rate (2020-2031)
2 Nateglinide Market by Type
2.1 Type Introduction
2.1.1 Tablet
2.1.2 Capsule
2.2 Global Nateglinide Market Size by Type
2.2.1 Global Nateglinide Market Size Overview by Type (2020-2031)
2.2.2 Global Nateglinide Historic Market Size Review by Type (2020-2025)
2.2.3 Global Nateglinide Market Size Forecasted by Type (2026-2031)
2.3 Global Nateglinide Market Size by Regions
2.3.1 North America Nateglinide Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Nateglinide Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Nateglinide Market Size Breakdown by Type (2020-2025)
2.3.4 South America Nateglinide Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Nateglinide Market Size Breakdown by Type (2020-2025)
3 Nateglinide Market by Application
3.1 Type Introduction
3.1.1 Used In Combination With Metformin
3.1.2 Used Alone
3.2 Global Nateglinide Market Size by Application
3.2.1 Global Nateglinide Market Size Overview by Application (2020-2031)
3.2.2 Global Nateglinide Historic Market Size Review by Application (2020-2025)
3.2.3 Global Nateglinide Market Size Forecasted by Application (2026-2031)
3.3 Global Nateglinide Market Size by Regions
3.3.1 North America Nateglinide Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Nateglinide Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Nateglinide Market Size Breakdown by Application (2020-2025)
3.3.4 South America Nateglinide Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Nateglinide Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics
4.1 Nateglinide Industry Trends
4.2 Nateglinide Industry Drivers
4.3 Nateglinide Industry Opportunities and Challenges
4.4 Nateglinide Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Nateglinide Revenue (2020-2025)
5.2 Global Nateglinide Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Nateglinide Key Company Headquarters & Area Served
5.4 Global Nateglinide Company, Product Type & Application
5.5 Global Nateglinide Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Nateglinide Market CR5 and HHI
5.6.2 Global Top 5 and 10 Nateglinide Players Market Share by Revenue in 2024
5.6.3 2024 Nateglinide Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Qilu Pharmaceutical Co., Ltd
6.1.1 Qilu Pharmaceutical Co., Ltd Comapny Information
6.1.2 Qilu Pharmaceutical Co., Ltd Business Overview
6.1.3 Qilu Pharmaceutical Co., Ltd Nateglinide Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Qilu Pharmaceutical Co., Ltd Nateglinide Product Portfolio
6.1.5 Qilu Pharmaceutical Co., Ltd Recent Developments
6.2 Chen Ho Pharmaceutical Co.,Ltd.Sinying Plant
6.2.1 Chen Ho Pharmaceutical Co.,Ltd.Sinying Plant Comapny Information
6.2.2 Chen Ho Pharmaceutical Co.,Ltd.Sinying Plant Business Overview
6.2.3 Chen Ho Pharmaceutical Co.,Ltd.Sinying Plant Nateglinide Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Chen Ho Pharmaceutical Co.,Ltd.Sinying Plant Nateglinide Product Portfolio
6.2.5 Chen Ho Pharmaceutical Co.,Ltd.Sinying Plant Recent Developments
6.3 Jiangsu Deyuan Pharmaceutical Co. Ltd
6.3.1 Jiangsu Deyuan Pharmaceutical Co. Ltd Comapny Information
6.3.2 Jiangsu Deyuan Pharmaceutical Co. Ltd Business Overview
6.3.3 Jiangsu Deyuan Pharmaceutical Co. Ltd Nateglinide Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Jiangsu Deyuan Pharmaceutical Co. Ltd Nateglinide Product Portfolio
6.3.5 Jiangsu Deyuan Pharmaceutical Co. Ltd Recent Developments
6.4 Beijing Novartis Pharmaceutical Co. Ltd
6.4.1 Beijing Novartis Pharmaceutical Co. Ltd Comapny Information
6.4.2 Beijing Novartis Pharmaceutical Co. Ltd Business Overview
6.4.3 Beijing Novartis Pharmaceutical Co. Ltd Nateglinide Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Beijing Novartis Pharmaceutical Co. Ltd Nateglinide Product Portfolio
6.4.5 Beijing Novartis Pharmaceutical Co. Ltd Recent Developments
6.5 Nivagen Pharmaceuticals, Inc.
6.5.1 Nivagen Pharmaceuticals, Inc. Comapny Information
6.5.2 Nivagen Pharmaceuticals, Inc. Business Overview
6.5.3 Nivagen Pharmaceuticals, Inc. Nateglinide Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Nivagen Pharmaceuticals, Inc. Nateglinide Product Portfolio
6.5.5 Nivagen Pharmaceuticals, Inc. Recent Developments
6.6 NIKSAN PHARMACEUTICAL
6.6.1 NIKSAN PHARMACEUTICAL Comapny Information
6.6.2 NIKSAN PHARMACEUTICAL Business Overview
6.6.3 NIKSAN PHARMACEUTICAL Nateglinide Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 NIKSAN PHARMACEUTICAL Nateglinide Product Portfolio
6.6.5 NIKSAN PHARMACEUTICAL Recent Developments
6.7 Caremark L.L.C.
6.7.1 Caremark L.L.C. Comapny Information
6.7.2 Caremark L.L.C. Business Overview
6.7.3 Caremark L.L.C. Nateglinide Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Caremark L.L.C. Nateglinide Product Portfolio
6.7.5 Caremark L.L.C. Recent Developments
6.8 AvKARE, Inc.
6.8.1 AvKARE, Inc. Comapny Information
6.8.2 AvKARE, Inc. Business Overview
6.8.3 AvKARE, Inc. Nateglinide Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 AvKARE, Inc. Nateglinide Product Portfolio
6.8.5 AvKARE, Inc. Recent Developments
7 North America
7.1 North America Nateglinide Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Nateglinide Market Size by Country (2020-2025)
7.3 North America Nateglinide Market Size Forecast by Country (2026-2031)
8 Europe
8.1 Europe Nateglinide Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Nateglinide Market Size by Country (2020-2025)
8.3 Europe Nateglinide Market Size Forecast by Country (2026-2031)
9 Asia-Pacific
9.1 Asia-Pacific Nateglinide Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Nateglinide Market Size by Country (2020-2025)
9.3 Asia-Pacific Nateglinide Market Size Forecast by Country (2026-2031)
10 South America
10.1 South America Nateglinide Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Nateglinide Market Size by Country (2020-2025)
10.3 South America Nateglinide Market Size Forecast by Country (2026-2031)
11 Middle East & Africa
11.1 Middle East & Africa Nateglinide Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Nateglinide Market Size by Country (2020-2025)
11.3 Middle East & Africa Nateglinide Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.